| # 430 Risk factors for major bleeding in patients with non-valvular atrial fibrillation and CKD G3-G5D on oral anticoagulants F Welander, H Renlund, A Själander Nephrology Dialysis Transplantation 39 (Supplement_1), gfae069-0066-430, 2024 | | 2024 |
| 5130 Association between degree of LDL-cholesterol decrease after a myocardial infarction and mortality-a nationwide cohort study J Schubert, B Lindahl, H Melhus, H Renlund, M Leosdottir, A Allahyari, ... European Heart Journal 40 (Supplement_1), ehz746. 0044, 2019 | | 2019 |
| 6011 Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction in relation to renal function: 1-year SWEDEHEART registry data R Edfors, AS Sahlen, KS Szummer, HR Renlund, ME Evans, JJ Carrero, ... European Heart Journal 38 (suppl_1), ehx493. 6011, 2017 | 3 | 2017 |
| A possible paradoxical association between LDL-cholesterol in myocardial infarction patients and relation to major adverse outcomes-a 10-year nationwide cohort study J Schubert, B Lindahl, H Melhus, H Renlund, M Leosdottir, A Allahyari, ... EUROPEAN HEART JOURNAL 40, 3222-3222, 2019 | | 2019 |
| Association between degree of LDL-cholesterol decrease after a myocardial infarction and mortality a nationwide cohort study J Schubert, B Lindahl, H Melhus, H Renlund, M Leosdottir, A Allahyari, ... EUROPEAN HEART JOURNAL 40, 3099-3099, 2019 | | 2019 |
| Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR P Sandén, H Renlund, PJ Svensson, A Själander Thrombosis and haemostasis 26 (01), 27-32, 2017 | 38 | 2017 |
| Bleeding complications in venous thrombosis patients on well-managed warfarin P Sandén, H Renlund, PJ Svensson, A Själander Journal of thrombosis and thrombolysis 41, 351-358, 2016 | 16 | 2016 |
| Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants N Wallvik, H Renlund, A Själander Journal of Thrombosis and Thrombolysis 52, 315-323, 2021 | 8 | 2021 |
| Causes, pattern, predictors and prognostic implications of new hospitalizations after TAVI: a long-term nationwide observational study K Nilsson, S Buccheri, C Christersson, S Koul, J Nilsson, P Pétursson Eur Heart J Qual Care Clin Outcomes, qcab026, 2021 | 1 | 2021 |
| Causes, pattern, predictors, and prognostic implications of new hospitalizations after transcatheter aortic valve implantation: a long-term nationwide observational study K Nilsson, S Buccheri, C Christersson, S Koul, J Nilsson, P Petursson, ... European Heart Journal-Quality of Care and Clinical Outcomes 8 (2), 150-160, 2022 | 6 | 2022 |
| Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary … KD Mahmoud, SS Jolly, S James, V Džavík, JA Cairns, GK Olivecrona, ... European Heart Journal 39 (26), 2472-2479, 2018 | 46 | 2018 |
| Clinical outcomes with unselected use of an ultrathin-strut sirolimus-eluting stent: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR): Ultrathin … S Buccheri, G Sarno, D Erlinge, H Renlund, B Lagerqvist, P Grimfjärd, ... EuroIntervention 16 (17), 1413, 2021 | 11 | 2021 |
| Computer aided warfarin dosing in the Swedish national quality registry AuriculA–Algorithmic suggestions are performing better than manually changed doses B Grzymala-Lubanski, S Själander, H Renlund, PJ Svensson, A Själander Thrombosis research 131 (2), 130-134, 2013 | 29 | 2013 |
| Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart … A Sahlen, C Varenhorst, B Lagerqvist, H Renlund, L Wallentin, SK James, ... European Heart Journal-Cardiovascular Pharmacotherapy 2 (1), 5-12, 2016 | 55 | 2016 |
| Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation S Själander, V Sjögren, H Renlund, B Norrving, A Själander Thrombosis research 167, 113-118, 2018 | 52 | 2018 |
| Direct Comparisons of Apixaban, Dabigatran and Rivaroxaban in Atrial Fibrillation MU Jansson, V Sjögren, S Själander, H Renlund, B Norrving, A Själander Circulation 138 (Suppl_1), A16533-A16533, 2018 | | 2018 |
| Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation M Jansson, S Själander, V Sjögren, H Renlund, B Norrving, A Själander Thrombosis Research 185, 135-141, 2020 | 17 | 2020 |
| Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D F Welander, H Renlund, E Dimény, H Holmberg, A Själander Clinical Kidney Journal 16 (5), 835-844, 2023 | 11 | 2023 |
| Effect of gender on patients with ST-elevation and non-ST-elevation myocardial infarction without obstructive coronary artery disease N Johnston, B Jönelid, C Christersson, T Kero, H Renlund, ... The American journal of cardiology 115 (12), 1661-1666, 2015 | 77 | 2015 |
| Effects of apixaban compared with warfarin as gain in event-free time–a novel assessment of the results of the ARISTOTLE trial E Berglund, L Wallentin, J Oldgren, H Renlund, JH Alexander, ... European Journal of Preventive Cardiology 27 (12), 1311-1319, 2020 | 6 | 2020 |
Stefan JamesUppsala University在 ucr.uu.se 的电子邮件经过验证
